Myeloma Developing Regimens Using Genomics (MyDRUG): Longitudinal Single-Cell Transcriptional Landscape of the Myeloma and Immune Microenvironment in Relapsed/Refractory Multiple Myeloma Patients Treated with MEK-Inhibitor, Cobimetinib
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7090-7091
10.1182/blood-2022-167462